TOI logo

ONCOLOGY INSTITUTE INC/THE

TOINASDAQ
US Equity
$5.13▼ $1.26 (−19.72%)
🌅 Pre-market$5.19▲ 1.07%Regular close · extended-hours price shown
🔔
Track TOI
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 19.7%
7d—
14d—
30d—
ytd▲ 44.5%
1y▲ 11.5%
🏦Market Cap
—
📈Revenue Growth (YoY)
35.4%
High Growth
📊Gross Margin
15.1%
Thin
💵FCF Margin
0.4%
Thin
⚖️P/S Ratio
0.9x
Cheap
Otter Score
56
Fair

Trading Snapshot

Day Range
$4.87 – $5.15
52-Week Range
$2.32 – $7.13
Volume (shares)
1,212,244
Avg Volume (shares)
—
Shares Outstanding
—
Next Earnings
—

Fundamentals Snapshot

Annual Revenue
$503M
Last Q Revenue
$161M
P/E Ratio
—
P/S Ratio
0.9x
EPS (TTM)
$-0.45
Dividend Yield
—
Dilution (1yr)
+1241.0%
TOI logo

ONCOLOGY INSTITUTE INC/THE

TOI
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$503M▲ +27.8% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
15.2%▲ +10.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$36M▼ −40.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$28M▼ −8.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.01B▲ +1241.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
−$70M▲ +$3M YoY
StockOtter · stockotter.space

About ONCOLOGY INSTITUTE INC/THE

The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Its comprehensive offerings include direct physician care, integrated on-site infusion and medication dispensing facilities, and advanced clinical trial management. The institute also provides radiation therapy, specialized outpatient programs for stem cell transplants and transfusions, and robust patient support services. Furthermore, TOI is actively involved in operating palliative care initiatives and overseeing clinical trials. These services are specifically designed to meet the needs of adult and senior cancer patients. The company maintains a significant operational footprint with 67 clinic locations. The Oncology Institute was established in 2007 and is headquartered in Cerritos, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
56/100
Analyst data unavailable.

Latest News & Updates

Defense World·Sep 3

BlackRock Inc. Buys Shares of 4,749,030 The Oncology Institute, Inc. $TOI

BlackRock Inc. purchased a new position in shares of The Oncology Institute, Inc. (NASDAQ: TOI) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund pur

Defense World·Aug 24

Head to Head Contrast: RadNet (NASDAQ:RDNT) and Oncology Institute (NASDAQ:TOI)

Oncology Institute (NASDAQ: TOI - Get Free Report) and RadNet (NASDAQ: RDNT - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength o

MarketBeat·Aug 7

Oncology Institute Q2 Earnings Call Highlights

Oncology Institute NASDAQ: TOI reported second-quarter revenue growth, positive adjusted EBITDA and an expanded pipeline of value-based oncology contracts as the company announced it has rebranded as Starling Oncology.

GlobeNewsWire·Aug 3

The Oncology Institute Rebrands as Starling Oncology

CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or “the Company”), one of the largest value-based oncology groups in the United States, announced today that it has rebranded to “St